Proteomic Analysis of Sera from Common Variable Immunodeficiency Patients Undergoing Replacement Intravenous Immunoglobulin Therapy

Table 2

Clinical and laboratory data of naive (N4–N9) and IVIg-treated patients (I4–I9) contributing to serum samples for western blot determinations of serum clusterin levels.

ID	Sex	Age (years)	Total protein level (g/dL)	Ig level (mg/dL)			ESR (mm/1st h)	CRP (mg/dL)	Observed complications
				IgG	IgA	IgM
N4	M	33	6.9	288	6.2	7.3	10	<0.31	R
N5	F	44	5.9	235	12.2	43.5	28	4.59	R, GI
N6	F	30	5.6	7	0	4.5	27	7.54	R, GI, M
N7	F	38	5.7	230	12.1	43.4	26	4.50	R, GI
N8	M	30	6.2	69	<6.2	<4.5	4	<0.31	R, GI, A
N9	F	13	6.6	253	6.2	8.2	8	0.75	R
I4	M	13	7.4	418	6.1	13.3	13	0.35	R, GI
I5	M	20	6.6	1000	13.9	54	12	0.31	R, GI
I6	F	39	7.1	910	5.8	15	10	0.31	R, GI
I7	F	19	6.4	700	6.1	10.5	7	0.33	R
I8	M	47	7.2	600	63	4.1	8	0.31	R, GI, A
I9	F	17	6.7	481	6.9	4.1	10	0.31	R, GI

ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; R: respiratory tract infections; GI: gastrointestinal tract infections; A: autoimmunity; M: malignancy.